ADVERTISEMENT

Zydus Lifesciences Q1 Results Review - Earnings Led By Multiple One-Offs: ICICI Securities

The company’s higher dependency on exclusive products may cap its earnings growth beyond FY25E, says the brokerage.

<div class="paragraphs"><p> Representational image (Source: Zydus Lifesciences website)</p></div>
Representational image (Source: Zydus Lifesciences website)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit